Literature DB >> 7565727

Accumulation of a novel spliceosomal complex on pre-mRNAs containing branch site mutations.

P Champion-Arnaud1, O Gozani, L Palandjian, R Reed.   

Abstract

Pre-mRNA assembles into spliceosomal complexes in the stepwise pathway E-->A-->B-->C. We show that mutations in the metazoan branchpoint sequence (BPS) have no apparent effect on E complex formation but block the assembly of the A complex and the UV cross-linking of U2 small nuclear ribonucleoprotein particle (snRNP) proteins. Unexpectedly, a novel complex, designated E*, assembles on pre-mRNAs containing BPS mutations. Unlike the E complex, the E* complex accumulates in the presence of ATP. U1 snRNP and U2AF, which are tightly bound to pre-mRNA in the E complex, are not tightly bound in the E* complex. Significantly, previous work showed that U1 snRNP and U2AF become destabilized from pre-mRNA after E complex assembly on normal pre-mRNAs. Thus, our data are consistent with a model in which there are two steps in the transition from the E complex to the A complex (E-->E*-->A). In the first step, U1 snRNP and U2AF are destabilized in an ATP-dependent, BPS-independent reaction. In the second step, the stable binding of U2 snRNP occurs in a BPS-dependent reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565727      PMCID: PMC230826          DOI: 10.1128/MCB.15.10.5750

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Specific and stable intron-factor interactions are established early during in vitro pre-mRNA splicing.

Authors:  B Ruskin; M R Green
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

2.  The role of the mammalian branchpoint sequence in pre-mRNA splicing.

Authors:  R Reed; T Maniatis
Journal:  Genes Dev       Date:  1988-10       Impact factor: 11.361

3.  Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

4.  Multiple interactions between the splicing substrate and small nuclear ribonucleoproteins in spliceosomes.

Authors:  B Chabot; J A Steitz
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

5.  U1 small nuclear ribonucleoproteins are required early during spliceosome assembly.

Authors:  M Zillmann; S D Rose; S M Berget
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Nonconsensus branch-site sequences in the in vitro splicing of transcripts of mutant rabbit beta-globin genes.

Authors:  R A Padgett; M M Konarska; M Aebi; H Hornig; C Weissmann; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Purification and visualization of native spliceosomes.

Authors:  R Reed; J Griffith; T Maniatis
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

8.  Identification of a functional mammalian spliceosome containing unspliced pre-mRNA.

Authors:  S M Abmayr; R Reed; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  Intron sequences involved in lariat formation during pre-mRNA splicing.

Authors:  R Reed; T Maniatis
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

10.  An ordered pathway of snRNP binding during mammalian pre-mRNA splicing complex assembly.

Authors:  A Bindereif; M R Green
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

View more
  19 in total

1.  Resolution of the mammalian E complex and the ATP-dependent spliceosomal complexes on native agarose mini-gels.

Authors:  R Das; R Reed
Journal:  RNA       Date:  1999-11       Impact factor: 4.942

2.  Sequences upstream of the branch site are required to form helix II between U2 and U6 snRNA in a trans-splicing reaction.

Authors:  G Ast; T Pavelitz; A M Weiner
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

3.  Reversible inhibition of the second step of splicing suggests a possible role of zinc in the second step of splicing.

Authors:  Noam Shomron; Hadar Malca; Ida Vig; Gil Ast
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

4.  Characterization of a U2AF-independent commitment complex (E') in the mammalian spliceosome assembly pathway.

Authors:  Oliver A Kent; Dustin B Ritchie; Andrew M Macmillan
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  Recognition of RNA branch point sequences by the KH domain of splicing factor 1 (mammalian branch point binding protein) in a splicing factor complex.

Authors:  H Peled-Zehavi; J A Berglund; M Rosbash; A D Frankel
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  Phosphoproteomic analysis of protein phosphorylation networks in Tetrahymena thermophila, a model single-celled organism.

Authors:  Miao Tian; Xiulan Chen; Qian Xiong; Jie Xiong; Chuanle Xiao; Feng Ge; Fuquan Yang; Wei Miao
Journal:  Mol Cell Proteomics       Date:  2013-11-07       Impact factor: 5.911

7.  The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.

Authors:  Z H Si; D Rauch; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  A role for SRp54 during intron bridging of small introns with pyrimidine tracts upstream of the branch point.

Authors:  C F Kennedy; A Krämer; S M Berget
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.

Authors:  David F Bishop; Xiaoye Schneider-Yin; Sonia Clavero; Han-Wook Yoo; Elisabeth I Minder; Robert J Desnick
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

10.  Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.

Authors:  S H Xiao; J L Manley
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.